Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 4/20 | 0.40 |
| ▸ | MME | P08473 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.38 |
| ▸ | CCKBR | P32239 | 1/20 | 0.37 |
| ▸ | REN | P00797 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6178297 | 0.87 | CCKBR (0.43) | ACEKMT2AL3MBTL1SCN9ACCKBR | |
| SCHEMBL6181583 | 0.87 | CCKBR (0.43) | ACEKMT2AL3MBTL1SCN9ACCKBR | |
| SCHEMBL6181104 | 0.87 | CCKBR (0.43) | ACEKMT2AL3MBTL1SCN9ACCKBR | |
| SCHEMBL6178675 | 0.86 | ACE (0.42) | ACEKMT2AL3MBTL1SCN9ACCKBR | |
| SCHEMBL6182762 | 0.86 | SCN9A (0.43) | ACEKMT2AL3MBTL1SCN9ACCKBR | |
| SCHEMBL6177390 | 0.85 | CCKBR (0.45) | ACEKMT2AL3MBTL1SCN9ACCKBR | |
| SCHEMBL7960849 | 0.84 | CCKBR (0.47) | ACEKMT2AL3MBTL1CCKBR | |
| SCHEMBL6177387 | 0.83 | ACE (0.40) | ACEMMESCN9ACCKBR | |
| SCHEMBL6178646 | 0.82 | POLB (0.43) | ACEKMT2AL3MBTL1SCN9ACCKBR | |
| SCHEMBL7958947 | 0.81 | SCN9A (0.40) | ACEKMT2AL3MBTL1SCN9ACCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013126797-A1 | CHOLECYSTOKININ B RECEPTOR TARGETING FOR IMAGING AND THERAPY | PURDUE RESEARCH FOUNDATION (US) | 2013-08-29 | — | — | WO | disclosed |